Wockhardt Ltd

NSE: WOCKPHARMA · BSE: 532300 · Pharmaceuticals & Biotechnology · 28 announcements

Share price: ₹2,151.00
Market cap: ₹34,952 Cr
Revenue (annual): ₹3,373 Cr
Net profit (annual): ₹213.0 Cr
P/E (TTM): 85.5×Sector 47.4×
Promoter holding: 49.08%+0.00% QoQ
FII holding: 7.23%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Board Meeting Date 5 Other Announcement 4 Annual General Meeting 4 Financial Results 3 Management Change 2 Legal & Regulatory 2 Earnings Call 2 Business Update 2 Results Update 1 Regulatory Approval 1 Fund Raise 1 Credit Rating 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

3 announcements with these filters

10 Aug 2026 15:24 IST BSE

Financial Results

Wockhardt Q1 FY27 Results: Turns Profitable, Net Profit ₹107 Cr

Wockhardt Ltd reported revenue from operations of ₹929 Cr (+25.9% YoY) and net profit of ₹107 Cr for Q1 FY27.

Key figure: Net profit ₹107 Cr

Open full results → Read the filing ↗

4 May 2026 15:30 IST BSE

Financial ResultsAlfa Alert

Wockhardt Q4 FY26 Results: Turns Profitable, Net Profit ₹164 Cr

Wockhardt Ltd reported revenue from operations of ₹965 Cr (+29.9% YoY) and net profit of ₹164 Cr for Q4 FY26.

Key figure: Net profit ₹164 Cr

Open full results → Read the filing ↗

4 May 2026 15:29 IST BSE

Financial Results

Wockhardt Financial Results

Wockhardt Ltd reported standalone total income of ₹1,876 Crore and net profit of ₹317 Crore for FY26. The Board also approved a proposal for fund raising through various equity and debt instruments. These results reflect a significant turnaround from the net loss recorded in the previous financial year.

Value: ₹1,876 Cr

Read the filing ↗